GALERA THERAPEUTICS

Galera Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on discovering and developing novel therapeutics targeting oxygen metabolic pathways with the potential to transform how radiation therapy is used in patients with cancer. Galera’s lead product candidate is GC4419, a highly selective and potent small molecule superoxide dismutase enzyme mimetic that rapidly converts superoxide to hydrogen peroxide and oxygen. GC4419 achieved positive results in a Phase ... 2b clinical trial, which demonstrated its ability to reduce the incidence and duration of radiation-induced severe oral mucositis in patients with head and neck cancer, it's lead indication. The U.S. Food and Drug Administration granted Fast Track and Breakthrough Therapy designations to GC4419. The company was established in 2009 and is headquartered in Malvern, Pennsylvania, United States.

#People #Financial #Event #Website #More

GALERA THERAPEUTICS

Social Links:

Industry:

Biotechnology Life Science Therapeutics

Founded:

2009-01-01

Address:

Malvern, Pennsylvania, United States

Country:

United States

Website Url:

http://www.galeratx.com

Total Employee:

11+

Status:

Active

Contact:

610-725-1500

Total Funding:

148.61 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics

Current Advisors List

henry-skinner_image

Henry Skinner Board of Directors @ Galera Therapeutics
Board_member

m-james-barrett_image

M. James Barrett Board of Directors @ Galera Therapeutics
Board_member

frank-torti_image

Frank Torti Board of Directors @ Galera Therapeutics
Board_member

Current Employees Featured

jennifer-evans-stacey_image

Jennifer Evans Stacey
Jennifer Evans Stacey Chief Legal and Compliance Officer (CLCO) & Secretary @ Galera Therapeutics
Chief Legal and Compliance Officer (CLCO) & Secretary
2021-10-01

sorensen-mel_image